Ironwood Pharmaceuticals, Inc. - (IRWD) Social Stream
IRONWOOD PHARMACEUTICALS INC (IRWD) Price Targets From Analysts
Use the tables below to see what analysts covering IRONWOOD PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $15 | $9 | $12.75 | $12.41 | 2.74% |
| 2022-01-10 | 3 | $15 | $9 | $12.333 | $12.41 | -0.62% |
| 2022-02-18 | 3 | $15 | $9 | $12 | $12.41 | -3.3% |
| 2022-05-02 | 4 | $16 | $9 | $13 | $12.41 | 4.75% |
| 2022-06-07 | 3 | $16 | $9 | $12.666 | $12.41 | 2.06% |
| 2022-08-05 | 3 | $16 | $9 | $12.667 | $12.41 | 2.07% |
| 2022-08-16 | 4 | $16 | $9 | $12.75 | $12.41 | 2.74% |
| 2022-11-04 | 5 | $16 | $9 | $13.2 | $12.41 | 6.37% |
| 2023-01-25 | 5 | $16 | $9 | $13.8 | $12.41 | 11.2% |
| 2023-02-17 | 5 | $16 | $9 | $13.6 | $12.41 | 9.59% |
| 2023-05-05 | 4 | $16 | $9 | $13.25 | $12.41 | 6.77% |
| 2023-08-02 | 4 | $19 | $9 | $14 | $12.41 | 12.81% |
| 2023-08-09 | 3 | $20 | $9 | $14.666 | $12.41 | 18.18% |
| 2023-09-28 | 4 | $20 | $9 | $14.666 | $12.41 | 18.18% |
| 2023-10-17 | 4 | $22 | $9 | $16.5 | $12.41 | 32.96% |
| 2023-11-10 | 5 | $22 | $9 | $17.4 | $12.41 | 40.21% |
The Trend in the Analyst Price Target
Over the past 42 months, IRWD's average price target has gone up $5.57.
IRWD reports an average of 35.09% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-17 | 5 | 16 | 9 | 13.60 | 11.85 | 14.77% |
| 2023-02-17 | 5 | 16 | 9 | 13.25 | 11.85 | 11.81% |
| 2023-04-27 | 4 | 16 | 9 | 13.25 | 10.42 | 27.16% |
| 2023-05-22 | 4 | 19 | 9 | 14.00 | 10.85 | 29.03% |
| 2023-08-08 | 4 | 20 | 9 | 14.25 | 10.31 | 38.22% |
IRWD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
IRWD's average broker recommendation rating improved by 0.93 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- IRONWOOD PHARMACEUTICALS INC's number of analysts covering the stock is higher than 224.98% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IRONWOOD PHARMACEUTICALS INC's average analyst price target is higher than 277.61% of them.
- IRONWOOD PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 304.91% of Pharmaceutical Products stocks.
- In the context of stocks in the mid market cap category, IRONWOOD PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1058.33% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IRONWOOD PHARMACEUTICALS INC are PCRX, EBS, and SUPN.
View All Top Stocks by Price Target
What is the outlook for IRWD? Use POWR Ratings for clearer insight into price direction.